[HTML] mdpi.com

[HTML][HTML] Protein–ligand docking in the machine-learning era

C Yang, EA Chen, Y Zhang - Molecules, 2022 - mdpi.com
Molecular docking plays a significant role in early-stage drug discovery, from structure-
based virtual screening (VS) to hit-to-lead optimization, and its capability and predictive …
被引用次数：69 相关文章

Protein–Ligand Docking in the Machine-Learning Era

C Yang, EA Chen, Y Zhang - Molecules, 2022 - search.proquest.com
Molecular docking plays a significant role in early-stage drug discovery, from structure-
based virtual screening (VS) to hit-to-lead optimization, and its capability and predictive …
[HTML] nih.gov

[HTML][HTML] Protein–Ligand Docking in the Machine-Learning Era

C Yang, EA Chen, Y Zhang - Molecules, 2022 - ncbi.nlm.nih.gov
Molecular docking plays a significant role in early-stage drug discovery, from structure-
based virtual screening (VS) to hit-to-lead optimization, and its capability and predictive …

Protein-Ligand Docking in the Machine-Learning Era.

C Yang, EA Chen, Y Zhang - Molecules (Basel, Switzerland), 2022 - europepmc.org
Molecular docking plays a significant role in early-stage drug discovery, from structure-
based virtual screening (VS) to hit-to-lead optimization, and its capability and predictive …

Protein-Ligand Docking in the Machine-Learning Era

C Yang, EA Chen, Y Zhang - Molecules (Basel …, 2022 - pubmed.ncbi.nlm.nih.gov
Molecular docking plays a significant role in early-stage drug discovery, from structure-
based virtual screening (VS) to hit-to-lead optimization, and its capability and predictive …

Protein–Ligand Docking in the Machine-Learning Era.

C Yang, EA Chen, Y Zhang - Molecules, 2022 - search.ebscohost.com
Molecular docking plays a significant role in early-stage drug discovery, from structure-
based virtual screening (VS) to hit-to-lead optimization, and its capability and predictive …

Protein–Ligand Docking in the Machine-Learning Era

C Yang, EA Chen, Y Zhang - Molecules, 2022 - nyuscholars.nyu.edu
Molecular docking plays a significant role in early-stage drug discovery, from structure-
based virtual screening (VS) to hit-to-lead optimization, and its capability and predictive …